AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25008027 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 75-mg
Number of subjects: 195
Study 23433324 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of intramuscular 17P, repeated twice weekly until 36 weeks or preterm delivery
Number of subjects: 0
Study 23433324 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0
Study 20101185 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone long-acting therapy (RLAT) 25 or 50 mg every 2 weeks
Number of subjects: 323
Study 20101185 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone long-acting therapy (RLAT)
Number of subjects: 323
Study 18439282 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 488
Study 18439282 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound physical therapy (UPT)
Number of subjects: 488
Study 18439282 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 488
Study 16169350 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II (previous PCI of original target lesion)
Number of subjects: 10000
Study 16169350 — intervention group
Group type: EXPERIMENTAL
Intervention: Group III (previous PCI of nontarget lesion)
Number of subjects: 10000
Study 16169350 — intervention group
Group type: COMPARATOR
Intervention: Group I (no previous PCI)
Number of subjects: 10000
Study 12672938 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined supplementation with 91 mg (136 iu) α-tocopherol and 250 mg of slow-release vitamin C twice a day for 3 years
Number of subjects: 107
Study 12672938 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 10533869 — intervention group
Group type: EXPERIMENTAL
Intervention: Female condom introduction
Number of subjects: 0
Study 10533869 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 8910177 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 555
Study 8910177 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 555
Study 1908372 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 200 micrograms q.i.d. for 4 weeks
Number of subjects: 94
Study 1908372 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine 200 mg q.i.d. for 4 weeks
Number of subjects: 94
Study 6857507 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical calf stimulation
Number of subjects: 150
Study 6857507 — intervention group
Group type: EXPERIMENTAL
Intervention: Low‐dose subcutaneous heparin
Number of subjects: 150
Study 6857507 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent sequential compression and thromboembolism‐deterrent (TED) stockings
Number of subjects: 150
Study 31004134 — intervention group
Group type: COMPARATOR
Intervention: NaPP:57Fe ratio 0:1
Number of subjects: 24
Study 31004134 — intervention group
Group type: COMPARATOR
Intervention: NaPP:57Fe ratio 3:1
Number of subjects: 24
Study 31004134 — intervention group
Group type: COMPARATOR
Intervention: NaPP:57Fe ratio 6:1
Number of subjects: 24
Study 30066681 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-adhering flowable composite (Fusio liquid dentin)
Number of subjects: 20
Study 30066681 — intervention group
Group type: COMPARATOR
Intervention: Conventional flowable composite (Tetric Flow)
Number of subjects: 20
Study 25583271 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular treatment
Number of subjects: 0
Study 25583271 — intervention group
Group type: COMPARATOR
Intervention: Standard manualized treatment
Number of subjects: 0
Study 25583271 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0
Study 24507754 — intervention group
Group type: EXPERIMENTAL
Intervention: Warming blood transfusion and infusion (WBI)
Number of subjects: 80
Study 24507754 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard blood transfusion)
Number of subjects: 80
Study 22484582 — intervention group
Group type: EXPERIMENTAL
Intervention: CTLA4Ig gene transfer via adenovirus vector (Ad‐CTLA4Ig‐EGFP)
Number of subjects: 0
Study 22484582 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CTLA4Ig gene transfer)
Number of subjects: 0
Study 21129689 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational Intervention (EI)
Number of subjects: 21
Study 21129689 — intervention group
Group type: COMPARATOR
Intervention: Control (pre-EI)
Number of subjects: 21
Study 21129689 — intervention group
Group type: COMPARATOR
Intervention: Control (post-EI)
Number of subjects: 21
Study 21129689 — intervention group
Group type: COMPARATOR
Intervention: Control (ICM use)
Number of subjects: 21
Study 17456287 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive processing of food cues in overweight adolescents
Number of subjects: 87
Study 17456287 — intervention group
Group type: COMPARATOR
Intervention: Cognitive processing of food cues in normal weight adolescents
Number of subjects: 87
Study 17456287 — intervention group
Group type: EXPERIMENTAL
Intervention: Thought suppression instruction
Number of subjects: 87
Study 15780039 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for breast cancer (mammography)
Number of subjects: 0
Study 15780039 — intervention group
Group type: COMPARATOR
Intervention: Screening for breast cancer (alternative methods)
Number of subjects: 0
Study 12065142 — intervention group
Group type: EXPERIMENTAL
Intervention: Active management of the third stage of labor with uterotonic drugs (Oxytocin preferred)
Number of subjects: 0
Study 12065142 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 0
Study 12065142 — intervention group
Group type: EXPERIMENTAL
Intervention: Active management of the third stage of labor
Number of subjects: 0
Study 9728155 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 1172
Study 9728155 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 1172
Study 8539677 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP titration using full polysomnography
Number of subjects: 41
Study 8539677 — intervention group
Group type: COMPARATOR
Intervention: CPAP titration using night time respiratory recordings
Number of subjects: 41
Study 2482193 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthracyclines 0.2 mumol/l
Number of subjects: 40
Study 2482193 — intervention group
Group type: EXPERIMENTAL
Intervention: Ara-C 0.5 mumol/l
Number of subjects: 40
Study 2482193 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of anthracyclines and Ara-C
Number of subjects: 40
Study 2482193 — intervention group
Group type: EXPERIMENTAL
Intervention: Incubations with 0.2 mumol/l anthracyclines and 0.5 mumol/l Ara-C
Number of subjects: 40
Study 2482193 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro drug sensitivity
Number of subjects: 40
Study 754843 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine pubic shaving prior to transurethral surgery
Number of subjects: 0
Study 754843 — intervention group
Group type: COMPARATOR
Intervention: No pubic shave
Number of subjects: 0
Study 30728055 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive VR and conventional rehabilitation
Number of subjects: 60
Study 30728055 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 60
Study 27932540 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help autogenic relaxation CD listened to five times a week for one month
Number of subjects: 15
Study 27932540 — intervention group
Group type: COMPARATOR
Intervention: Control group received treatment after three months
Number of subjects: 15
Study 26022802 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress condition
Number of subjects: 133
Study 26022802 — intervention group
Group type: EXPERIMENTAL
Intervention: Food cues condition
Number of subjects: 133
Study 23670112 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-session intervention aimed at increasing adherence via implementation intentions and modifying mistaken beliefs about medication/stroke.
Number of subjects: 62
Study 23670112 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 62
Study 21300940 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (20 mg)
Number of subjects: 22
Study 21300940 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 19552805 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injection
Number of subjects: 132
Study 19552805 — intervention group
Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 132
Study 19552805 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injection with physiotherapy (8 sessions over 8 weeks)
Number of subjects: 132
Study 19552805 — intervention group
Group type: COMPARATOR
Intervention: Saline injection with physiotherapy (8 sessions over 8 weeks)
Number of subjects: 132
Study 17342556 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic colon resection (LCR)
Number of subjects: 285
Study 17342556 — intervention group
Group type: COMPARATOR
Intervention: Open colon resection (OCR)
Number of subjects: 285
Study 16132320 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical training system
Number of subjects: 32
Study 16132320 — intervention group
Group type: COMPARATOR
Intervention: Virtual reality training system
Number of subjects: 32
Study 11943519 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 180 mg with midazolam 20 mg (HM group)
Number of subjects: 100
Study 11943519 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 90 mg with midazolam 20 mg (LM group)
Number of subjects: 100
Study 11943519 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 180 mg without midazolam (HC group)
Number of subjects: 100
Study 11943519 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 90 mg without midazolam (LC group)
Number of subjects: 100
Study 9495418 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural infusion of alfentanil (0.36 mg/h) plus bupivacaine (10 mg/h)
Number of subjects: 32
Study 9495418 — intervention group
Group type: COMPARATOR
Intervention: i.v. infusion of alfentanil (0.36 mg/h) plus bupivacaine (10 mg/h)
Number of subjects: 32
Study 7710445 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg b.i.d. and clarithromycin 500 mg q.i.d. (group 1)
Number of subjects: 40
Study 7710445 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg q.i.d. and clarithromycin 500 mg q.i.d. (group 2)
Number of subjects: 40
Study 2468702 — intervention group
Group type: EXPERIMENTAL
Intervention: Grass pollen immunotherapy
Number of subjects: 24
Study 2468702 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 1078803 — intervention group
Group type: EXPERIMENTAL
Intervention: Portacaval anastomosis (PCA)
Number of subjects: 108
Study 1078803 — intervention group
Group type: COMPARATOR
Intervention: Control Group (unoperated)
Number of subjects: 108
Study 1078803 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Control and Shunt)
Number of subjects: 108
Study 1078803 — intervention group
Group type: EXPERIMENTAL
Intervention: Shunt Group
Number of subjects: 108
Study 1078803 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 108
Study 30886131 — intervention group
Group type: EXPERIMENTAL
Intervention: Transversalis fascia plane (TFP) block with 20 ml of 0.5% ropivacaine
Number of subjects: 50
Study 30886131 — intervention group
Group type: EXPERIMENTAL
Intervention: Transversalis fascia plane (TFP) block with 5% dextrose
Number of subjects: 50
Study 30886131 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TFP block)
Number of subjects: 50
Study 28796053 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-day berberine-containing quadruple therapy
Number of subjects: 612
Study 28796053 — intervention group
Group type: COMPARATOR
Intervention: 14-day bismuth-containing quadruple therapy
Number of subjects: 612
Study 26595030 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated abdominoplasty without rectus fascia plication
Number of subjects: 94
Study 26595030 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated abdominoplasty with rectus fascia plication
Number of subjects: 94
Study 26595030 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in Short-Form physical function subscale after abdominoplasty
Number of subjects: 94
Study 23174856 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich concentrated beetroot juice (BR; 2 × 70 ml/day, ∼9.6 mmol/day NO(3)(‐))
Number of subjects: 12
Study 23174856 — intervention group
Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice placebo (PL; 2 × 70 ml/day, ∼0.01 mmol/day NO(3)(‐))
Number of subjects: 12
Study 21774637 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching algorithms
Number of subjects: 17
Study 21774637 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching ECG
Number of subjects: 17
Study 21774637 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation without teaching
Number of subjects: 17
Study 21774637 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching vs Preparation
Number of subjects: 17
Study 21774637 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching vs Preparation (60 days later)
Number of subjects: 17
Study 19670454 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin and gemcitabine (AG) followed by paclitaxel and cisplatin (Protocol A)
Number of subjects: 50
Study 19670454 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin and gemcitabine (AG) followed by paclitaxel plus carboplatin (Protocol B)
Number of subjects: 50
Study 19670454 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (Control group)
Number of subjects: 50
Study 15753134 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal (17.5 g fat)
Number of subjects: 0
Study 15753134 — intervention group
Group type: COMPARATOR
Intervention: Low-fat meal (2.7 g fat)
Number of subjects: 0
Study 15753134 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat toast and butter (17.5 g fat)
Number of subjects: 0
Study 15753134 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (400 mg/day, 4 weeks)
Number of subjects: 0
Study 15753134 — intervention group
Group type: EXPERIMENTAL
Intervention: ApoE3 subjects
Number of subjects: 0
Study 15753134 — intervention group
Group type: COMPARATOR
Intervention: ApoE4 subjects
Number of subjects: 0
Study 10519497 — intervention group
Group type: EXPERIMENTAL
Intervention: Mivazerol
Number of subjects: 1897
Study 10519497 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1897
Study 7742830 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral theophylline (350 mg b.i.d.)
Number of subjects: 6
Study 7742830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 2330167 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacu‐Cut needle (19.5 G)
Number of subjects: 20
Study 2330167 — intervention group
Group type: COMPARATOR
Intervention: Menghini needle (17 G)
Number of subjects: 20
Study 7016124 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel (1 x 30 mg/kg, 1 x 40 mg/kg, 2 x 20 mg/kg)
Number of subjects: 90
Study 7016124 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 x 40 mg/kg)
Number of subjects: 90
Study 30715561 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthogeriatric comanagement (OGC)
Number of subjects: 430
Study 30715561 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Consultant Service (GCS)
Number of subjects: 430
Study 28971980 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolomic profiling in Study B (n=166)
Number of subjects: 589
Study 28971980 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolomic profiling in Study A (n=423)
Number of subjects: 589
Study 26073279 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA (100mg)
Number of subjects: 10
Study 26073279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 26073279 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA (100mg) + MDMA (100mg)
Number of subjects: 10
Study 26073279 — intervention group
Group type: COMPARATOR
Intervention: Placebo + MDMA (100mg)
Number of subjects: 10
Study 24322572 — intervention group
Group type: EXPERIMENTAL
Intervention: Low BIS (30‐40)
Number of subjects: 135
Study 24322572 — intervention group
Group type: COMPARATOR
Intervention: High BIS (45‐60)
Number of subjects: 135
Study 22665339 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar plasmakinetic TURP (PK‐TURP)
Number of subjects: 220
Study 22665339 — intervention group
Group type: COMPARATOR
Intervention: Monopolar TURP (M‐TURP)
Number of subjects: 220
Study 20081393 — intervention group
Group type: EXPERIMENTAL
Intervention: Multipronged intervention including staff training, couples family planning sessions, and free provision of hormonal contraception on‐site
Number of subjects: 213
Study 20081393 — intervention group
Group type: COMPARATOR
Intervention: No intervention (other Kenyan sites)
Number of subjects: 213
Study 17377889 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback provided to therapists after the first half of the chat session.
Number of subjects: 86
Study 17377889 — intervention group
Group type: COMPARATOR
Intervention: Non-feedback sessions (control group).
Number of subjects: 86
Study 15385359 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane inhalation combined with positive pressure ventilation (PPV)
Number of subjects: 40
Study 15385359 — intervention group
Group type: COMPARATOR
Intervention: Total IV anesthesia (TIVA) combined with positive pressure ventilation (PPV)
Number of subjects: 40
Study 11496849 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiarrhythmic-drug therapy
Number of subjects: 758
Study 11496849 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator
Number of subjects: 758
Study 11496849 — intervention group
Group type: EXPERIMENTAL
Intervention: Driving after resumption
Number of subjects: 758
Study 9526748 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-examiner reliability assessment using mechanical pressure algometer
Number of subjects: 21
Study 9526748 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-examiner reliability assessment
Number of subjects: 21
Study 9526748 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-examiner coefficient of variation
Number of subjects: 21
Study 9526748 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-examiner coefficient of variation
Number of subjects: 21
Study 9526748 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-examiner coefficient of repeatability (CR)
Number of subjects: 21
Study 9526748 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-examiner coefficient of repeatability (CR)
Number of subjects: 21
Study 9526748 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of frontal point differences between examiners
Number of subjects: 21
Study 9526748 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of non-significant points
Number of subjects: 21
Study 9526748 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-examiner reliability of side differences
Number of subjects: 21
Study 7913326 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine 500 mg twice daily for 104 weeks (initially 250 mg four times daily for the first 4 weeks)
Number of subjects: 329
Study 7913326 — intervention group
Group type: COMPARATOR
Intervention: Placebo twice daily for 104 weeks
Number of subjects: 329
Study 7913326 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 329
Study 7913326 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 329
Study 31919579 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilastine 10 mg/day
Number of subjects: 0
Study 31919579 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30169323 — intervention group
Group type: EXPERIMENTAL
Intervention: Late parenteral nutrition (withholding for 1 week)
Number of subjects: 209
Study 30169323 — intervention group
Group type: EXPERIMENTAL
Intervention: Late parenteral nutrition
Number of subjects: 209
Study 30169323 — intervention group
Group type: COMPARATOR
Intervention: Early parenteral nutrition (initiated within 24 h)
Number of subjects: 209
Study 27566413 — intervention group
Group type: EXPERIMENTAL
Intervention: Belotecan/cisplatin (BP)
Number of subjects: 147
Study 27566413 — intervention group
Group type: COMPARATOR
Intervention: Etoposide/cisplatin (EP)
Number of subjects: 147
Study 25648301 — intervention group
Group type: EXPERIMENTAL
Intervention: TRANSFoRm-supported recruitment
Number of subjects: 0
Study 25648301 — intervention group
Group type: COMPARATOR
Intervention: Standard opportunistic recruitment (Control)
Number of subjects: 0
Study 22928590 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS biosignal
Number of subjects: 34
Study 22928590 — intervention group
Group type: EXPERIMENTAL
Intervention: Entropy biosignal
Number of subjects: 34
Study 22928590 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS biosignal with 0.6 mg/kg rocuronium
Number of subjects: 34
Study 22928590 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS biosignal with 1.2 mg/kg rocuronium
Number of subjects: 34
Study 22928590 — intervention group
Group type: EXPERIMENTAL
Intervention: Entropy biosignal with 0.6 mg/kg rocuronium
Number of subjects: 34
Study 22928590 — intervention group
Group type: EXPERIMENTAL
Intervention: Entropy biosignal with 1.2 mg/kg rocuronium
Number of subjects: 34
Study 21115455 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftaroline fosamil 600 mg every 12 h for 5-14 days
Number of subjects: 694
Study 21115455 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin plus aztreonam 1 g every 12 h for 5-14 days
Number of subjects: 694
Study 21115455 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftaroline fosamil
Number of subjects: 694
Study 21115455 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin plus aztreonam
Number of subjects: 694
Study 21115455 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftaroline fosamil and Vancomycin plus aztreonam
Number of subjects: 694
Study 19722444 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-layer application of self-etching primer (Clearfil SE Bond) with no contamination (group 1)
Number of subjects: 56
Study 19722444 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-layer application of self-etching primer (Clearfil SE Bond) with no contamination (group 2)
Number of subjects: 56